Last reviewed · How we verify
NCT00311974
The Effect of Dihydralazine on Renal Tubular Function and Vasoactive Hormones in Healthy Individuals
Phase 4 trial testing Dihydralazine in Healthy in 16 participants. Completed in 1 November 2007.
1 November 2007
Quick facts
| Lead sponsor | Regional Hospital Holstebro |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Enrollment | 16 |
| Start date | 1 April 2006 |
| Primary completion | 1 November 2007 |
| Estimated completion | 1 November 2007 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Dihydralazine (DIHYDRALAZINE) — full drug profile →
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Regional Hospital Holstebro
Who can join
Adults 18 to 40, male only, with Healthy. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
- Fractional sodium excretion
- Heart rate
- Blood pressure
Sponsor's own description
We, the investigators at Holstebro Hospital, want to test the hypothesis that dihydralazine leads to the activation of the sympathetic nervous system in healthy individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00311974
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Regional Hospital Holstebro trials
Trials by the same sponsor.
- NCT05165823 — The Significance of Sodium Balance and the Value of Salt-blood Test in Identifying Salt Sensitive Patients · NA · completed
- NCT04363554 — The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease · NA · completed
- NCT06019026 — Five-year Migration Pattern and Bone Mineral Density for the Tri-Lock and Summit Femoral Stems. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00311974 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Regional Hospital Holstebro
- Last refreshed: 17 February 2010
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00311974.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing